IP Library Granted Patent US 10,513,687
Granted Patent B2
US 10,513,687 · App. 14/035,809 · Granted Dec 24, 2019

Method for polyclonal stimulation of T cells by flexible nanomatrices

Inventors: Alexander Scheffold (Joachim Friedrich, DE); Mario Assenmacher (Bergisch-Gladbach, DE)
Assignee: Miltenyi Biotec GmbH
C12N5/0637A61K35/17C12N5/0075C12N5/0636C12N2501/51C12N2501/515C12N2501/998C12N2533/70C12N2539/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,513,687
App. No.
14/035,809
Granted
Dec 24, 2019
Kind
B2
Abstract

The present invention provides a method polyclonal stimulation of T cells, the method comprising contacting a population of T cells with a nanomatrix, the nanomatrix comprising a) a flexible matrix, wherein said matrix is of polymeric material; and b) attached to said polymeric flexible matrix one or more polyclonal stimulatory agents which provide activation signals to the T cells; thereby activating and inducing the T cells to proliferate; wherein the nanomatrix is 1 to 500 nm in size. At least one first and one second stimulatory agents are attached to the same or to separate flexible matrices. If the stimulatory agents are attached to separate beads, fine-tuning of nanomatrices for the stimulation of the T cells is possible.

Claims (14)

1. An in vitro method for polyclonal stimulation of T cells, the method comprising contacting a population of T cells with a nanomatrix, the nanomatrix comprising

a) a flexible matrix, wherein said matrix is of polymeric dextran material having an average molecular weight of 40,000 daltons; and

b) attached to said polymeric flexible matrix agents for polyclonal stimulation which provide activation signals to the T cells; thereby activating and inducing the T cells to proliferate, wherein the agents for polyclonal stimulation are anti-CD3 antibodies or antigen binding fragments thereof and anti-CD28 antibodies or antigen binding fragments thereof, wherein the anti-CD3 antibodies or antigen binding fragments thereof and the anti-CD28 antibodies or antigen binding fragments thereof are attached to the same flexible matrix or attached to separate flexible matrices.

2. The method according to claim 1 , wherein the nanomatrix is biologically inert with regard to alteration of the cell function.

3. The method according to claim 1 wherein at least one first and one second stimulatory agents are attached to the same flexible matrix.

4. The method according to claim 1 wherein at least one first and one second stimulatory agents are attached to separate flexible matrices.

5. The method according to claim 4 , wherein the ratio of nanomatrices to cells is larger than 500:1 allowing fine-tuning of T cell stimulation.

6. The method according to claim 1 wherein the nanomatrix is biodegradable.

7. The method according to claim 1 , wherein the nanomatrix carries magnetic, paramagnetic or superparamagnetic nano-crystals, embedded into the flexible matrix.

8. The method according to claim 1 , wherein the agent for polyclonal stimulation is attached at high density with more than 25 μg per mg nanomatrix.

9. The method according to claim 1 , wherein the stimulated T cells are Treg cells.

10. The method according to claim 1 , wherein the method is used within a closed cell culture system.

11. The method according to claim 1 , wherein said agents are antigen binding portions of an antibody.

12. The method according to claim 1 , wherein said agents are Fabs.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2019
From: MILTENYI BIOTEC GMBH
To: MILTENYI BIOTEC B.V. & CO. KG
Reel/Frame 051443/0669 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 032250 FRAME: 0706. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 23, 2017
From: SCHEFFOLD, ALEXANDER; ASSENMACHER, MARIO
To: MILTENYI BIOTEC GMBH
Reel/Frame 043656/0965 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2014
From: SCHEFFOLD, ALEXANDER; ASSENMACHER, MARIO
To: MILTENYI BIOTECH GMBH
Reel/Frame 032250/0706 →